Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites
- 1 December 2002
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 84 (3), 137-150
- https://doi.org/10.1016/s0168-3659(02)00261-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)–diacrylate macromers as crosslinking agents and characterization of their degradation productsPolymer, 2000
- Marrow stromal osteoblast function on a poly(propylene fumarate)/β-tricalcium phosphate biodegradable orthopaedic compositeBiomaterials, 2000
- Thrombin Peptide, TP508, Induces Differential Gene Expression in Fibroblasts through a Nonproteolytic Activation PathwayExperimental Cell Research, 1999
- Microparticles of poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug deliveryJournal of Controlled Release, 1997
- In VitroDegradation of a Poly(Propylene Fumarate)/β-Tricalcium Phosphate Composite Orthopaedic ScaffoldTissue Engineering, 1997
- Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymersBiomaterials, 1996
- Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2)Journal of Controlled Release, 1995
- The Ingrowth of New Bone Tissue and Initial Mechanical Properties of a Degrading Polymeric Composite ScaffoldTissue Engineering, 1995
- Fabrication of Controlled Release Biodegradable Foams by Phase SeparationTissue Engineering, 1995
- Bone Transplantation and Human Immunodeficiency VirusClinical Orthopaedics and Related Research, 1989